Developing the next generation of cancer imaging agents
We are interested in the discovery and development of new PET and MR methods to image tumour metabolism and the downstream effect of targeted therapeutics.
The development of a new generation of molecular imaging techniques will focus on cancer detection, assess the efficacy of novel and preexisting cancer therapeutics, and help describe the fundamental biological mechanisms that drive treatment resistance.
LATEST NEWS: New paper alert! Raul’s paper on the design and development of a novel ALDH1A1 radiotracer for the assessment of cancer drug resistance has been published in Chemistry A European Journal. Click on the image below to read.